Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

[Efficacy and safety of compound oxycodone injection for cancer pain relief-a multicenter survey of prescriptions].

Yoshimoto T, Hisada A, Yomiya K, Tomiyasu S, Hasegawa T, Murakami S, Matoba M.

Gan To Kagaku Ryoho. 2010 May;37(5):871-8. Japanese.

PMID:
20495318
2.

[Efficacy and safety of continuous subcutaneous injection of the compound oxycodone in cancer pain management: the first 4-year audit].

Yoshimoto T, Hisada A, Hasegawa T, Nozaki Y, Matoba M; Symptom Control Research Group SCORE-G.

Gan To Kagaku Ryoho. 2009 Oct;36(10):1683-9. Japanese.

PMID:
19838028
3.

[Retrospective study on intravenous compound injection of cancer pain patients with oxycodone and hydrocotarnine preparation in comparison with subcutaneous administration].

Sano T, Akagi T, Yokote N, Shuto C, Kudo N, Miura K, Murakami S, Saito O, Yamamoto H, Matoba M.

Gan To Kagaku Ryoho. 2012 May;39(5):769-75. Japanese.

PMID:
22584329
4.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
5.

[Conversion ratio between intravenous oxycodone/hydrocotarnine and sustained-release oral oxycodone in patients with cancer pain].

Kokubun H, Nakamura K, Fukawa M, Matoba M, Hoka S, Yago K.

Gan To Kagaku Ryoho. 2007 Dec;34(13):2255-8. Japanese.

PMID:
18079625
7.

Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.

Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harsanyi Z, Babul N, Ford I.

J Clin Oncol. 1998 Oct;16(10):3222-9.

PMID:
9779695
8.

Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.

Miyazaki T, Hanaoka K, Namiki A, Ogawa S, Kitajima T, Hosokawa T, Ishida T, Nogami S, Mashimo S.

Clin Drug Investig. 2008;28(5):313-25.

PMID:
18407717
9.

Dose-ranging study of oxycodone for chronic pain in advanced cancer.

Glare PA, Walsh TD.

J Clin Oncol. 1993 May;11(5):973-8.

PMID:
8487060
10.

Controlled-release oxycodone and morphine in cancer related pain.

Heiskanen T, Kalso E.

Pain. 1997 Oct;73(1):37-45.

PMID:
9414055
11.

Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.

Silvestri B, Bandieri E, Del Prete S, Ianniello GP, Micheletto G, Dambrosio M, Sabbatini G, Endrizzi L, Marra A, Aitini E, Calorio A, Garetto F, Nastasi G, Piantedosi F, Sidoti V, Spanu P.

Clin Drug Investig. 2008;28(7):399-407.

PMID:
18544000
12.

Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain.

Pan H, Zhang Z, Zhang Y, Xu N, Lu L, Dou C, Guo Y, Wu S, Yue J, Wu D, Dai Y.

Clin Drug Investig. 2007;27(4):259-67.

PMID:
17358098
13.

Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.

Narabayashi M, Saijo Y, Takenoshita S, Chida M, Shimoyama N, Miura T, Tani K, Nishimura K, Onozawa Y, Hosokawa T, Kamoto T, Tsushima T; Advisory Committee for Oxycodone Study.

Jpn J Clin Oncol. 2008 Apr;38(4):296-304. doi: 10.1093/jjco/hyn010. Epub 2008 Mar 7.

14.

Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.

Tessaro L, Bandieri E, Costa G, Fornasier G, Iorno V, Pizza C, Pastacaldi G, Micheletto G.

Eur Rev Med Pharmacol Sci. 2010 Feb;14(2):113-21.

PMID:
20329570
15.

Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.

Miner JR, Moore J, Gray RO, Skinner L, Biros MH.

Acad Emerg Med. 2008 Dec;15(12):1234-40. doi: 10.1111/j.1553-2712.2008.00266.x. Epub 2008 Oct 17.

16.

Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.

Citron ML, Kaplan R, Parris WC, Croghan MK, Herbst LH, Rosenbluth RJ, Reder RF, Slagle NS, Buckley BJ, Kaiko RF.

Cancer Invest. 1998;16(8):562-71.

PMID:
9844616
17.

Morphine and oxycodone hydrochloride in the management of cancer pain.

Kalso E, Vainio A.

Clin Pharmacol Ther. 1990 May;47(5):639-46.

PMID:
2188774
18.

Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.

Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K, Friedman M, Colucci SV, Richards P.

Clin J Pain. 2007 May;23(4):287-99.

PMID:
17449988
19.

Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain.

Palangio M, Morris E, Doyle RT Jr, Dornseif BE, Valente TJ.

Clin Ther. 2002 Jan;24(1):87-99.

PMID:
11833838
20.

Characterizations of long-term oxycodone/acetaminophen prescriptions in veteran patients.

Hermos JA, Young MM, Gagnon DR, Fiore LD.

Arch Intern Med. 2004 Nov 22;164(21):2361-6.

PMID:
15557416
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk